Translational research on the implementation of a diabetes prevention intervention in China
The Diabetes Prevention Program (DPP) is an evidence-based behavioral modification program to prevent diabetes. A current priority in global health is the translation of evidence-based programs in order to demonstrate their effectiveness in new settings. With the financial support of The International Diabetes Federation, the DPP was used as a model to design the Pathway to Health (PATH): A Lifestyle Intervention to Prevent Diabetes. The two aims of this translational research project were to assess the feasibility and sustainability of the PATH program, and to evaluate the effectiveness of the program. Feasibility and sustainability was determined by qualitative evaluation of local agencies involved in the program, as well as cultural variables which contributed to the sustained involvement of the women who participated. Effectiveness was determined by comparing type 2 diabetes risk factors (body weight and HbA1C level) in the intervention and control groups.
This presentation will also introduce cultural challenges involved in translational research and program implementation.
Learning Areas:Administer health education strategies, interventions and programs
Basic medical science applied in public health
Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Discuss the characteristics of China’s current diabetes epidemic. Describe a culturally appropriate diabetes prevention program for China. Evaluate the challenges of translational research.
Keyword(s): Diabetes, Chronic Disease Prevention
Qualified on the content I am responsible for because: I am qualified to make this presentation because I am P.I. on the IDF-funded grant reported on in this poster. I have lived more than ten years in China and am fluent in Mandarin Chinese. I have conducted research and published extensively on chronic disease in China.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.